Current investments
We have one or more companies open for investments. Please login or create an account to learn more and invest.
Completed investments
Akiram Therapeutics
Akiram has developed a new type of targeted radioimmunotherapy with the potential to become first-in-class. In animal studies, the survival rate has been 100%, and the tumours have been eradicated with just one treatment.
Pharmnovo AB
PharmNovo develops a novel drug for nerve pain, where there is a high, unmet need for effective and safe treatments. The candidate PN6047 shows effective pain relief in animal models, without the negative side effects associated with existing drugs.
Capitainer AB
Capitainer offers a more convenient and cost-efficient way to take blood samples. The company’s products are designed for home sampling and deliver an exact amount of blood, which is essential to get accurate results.
Exits
Liv Diagnostics
Tumor cell proliferation causes 90% of all cancer deaths. Liv Diagnostics is developing new technology to measure the spreading capacity of tumor cells and provide predictive information on the risk of metastasis.
Read moreRaytelligence
Raytelligence has developed a unique, non-intrusive radar sensor and cloud platform for monitoring vital signs, such as respiration, heartbeat and position and movement. The company focuses on elderly care in the home.
Read moreLearning to Sleep
Learning to Sleep is a digital sleep clinic. The company offers an evidence-based treatment that uniquely combines support from a sleep coach with digital aids.
Read more